Gujarat Kidney

INR
113.65
-0.3 (-0.26%)
BSENSE

Feb 18

BSE+NSE Vol: 5.27 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

5.27 lacs (-42.13%) Volume

Shareholding (Dec 2025)

FII

10.47%

Held by 9 FIIs

DII

1.67%

Held by 1 DIIs

Promoter

71.45%

When is the next results date for Gujarat Kidney & Super Speciality Ltd?

12-Feb-2026

The next results date for Gujarat Kidney & Super Speciality Ltd is 14 February 2026.

The next results date for Gujarat Kidney & Super Speciality Ltd is scheduled for 14 February 2026.

View full answer

Why is Gujarat Kidney & Super Speciality Ltd falling/rising?

18-Feb-2026

As of 17-Feb, the stock price of Gujarat Kidney & Super Speciality Ltd is rising, currently at Rs 113.80, reflecting a change of 2.1 (1.88%) upwards. The stock has outperformed the market with a year-to-date increase of 10.75%, despite a decline in investor participation.

As of 17-Feb, the stock price of Gujarat Kidney & Super Speciality Ltd is rising, currently at Rs 113.80, reflecting a change of 2.1 (1.88%) upwards. This upward movement can be attributed to several factors. Over the past week, the stock has increased by 1.61%, while the benchmark Sensex has declined by 0.98%, indicating that Gujarat Kidney is outperforming the market. In the past month, the stock has shown a significant gain of 10.70%, compared to a slight decrease in the Sensex of 0.14%. Year-to-date, the stock has also risen by 10.75%, while the Sensex has fallen by 2.08%.<BR><BR>Today's performance highlights that the stock has outperformed its sector by 2.12% and has been on a consecutive gain streak for the last two days, accumulating a total return of 3.08% during this period. The stock reached an intraday high of Rs 114.25, which is a 2.28% increase. Furthermore, Gujarat Kidney is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend.<BR><BR>However, it is worth noting that there has been a decline in investor participation, with delivery volume dropping by 54.24% compared to the 5-day average. Despite this decrease in volume, the stock remains liquid enough for trading, indicating that the price rise is supported by sufficient market activity. Overall, the combination of strong performance metrics and positive relative strength against the benchmark contributes to the rising stock price of Gujarat Kidney & Super Speciality Ltd.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

INR 899 Cr (Micro Cap)

stock-summary
P/E

98.00

stock-summary
Industry P/E

60

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.42

stock-summary
Return on Equity

498.28%

stock-summary
Price to Book

490.75

Revenue and Profits:
Net Sales:
23 Cr
(Quarterly Results - Dec 2025)
Net Profit:
3 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Statement Of Deviation And Variation For Quarter Ended 31 Decembre 2025

15-Feb-2026 | Source : BSE

Statement of deviation and variation for 31 december 2025

Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

15-Feb-2026 | Source : BSE

Intimation under Regulation 30 under LODR regulation 2015 we would like to inform you that we received order from NCLT Ahmedabad under section 131 of the Companies Act 2013.

Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025

14-Feb-2026 | Source : BSE

Outcome of Board meeting held on 14th February 2026 for the approval of unaudited financial result standalone and consolidated of the company for quarter and nine months ended December 312025 and other business matters.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
12.52
Debt to EBITDA (avg)
1.25
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.32
Tax Ratio
24.71%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.15%
ROCE (avg)
49.23%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
98
Industry P/E
60
Price to Book Value
490.10
EV to EBIT
71.63
EV to EBITDA
58.05
EV to Capital Employed
345.30
EV to Sales
25.50
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
482.06%
ROE (Latest)
498.28%

Technicals key factors

Indicator
Weekly
Monthly
Icon
No records
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 9 FIIs (10.47%)

Promoter with highest holding

Pragnesh Yashwantsinh Bharpoda (38.16%)

Highest Public shareholder

Craft Emerging Market Fund Pcc-citadel Capital Fund (3.89%)

Individual Investors Holdings

11.57%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 1.24% vs 13.28% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 1.30% vs 4.07% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.76",
          "val2": "9.64",
          "chgp": "1.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.14",
          "val2": "4.09",
          "chgp": "1.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.29",
          "val2": "0.23",
          "chgp": "26.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.33",
          "val2": "2.30",
          "chgp": "1.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "42.42%",
          "val2": "42.43%",
          "chgp": "-0.01%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Gujarat Kidney"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Gujarat Kidney"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "35.17",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.45",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.53",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.11",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "43.93%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
9.76
9.64
1.24%
Operating Profit (PBDIT) excl Other Income
4.14
4.09
1.22%
Interest
0.29
0.23
26.09%
Exceptional Items
0.00
0.00
Standalone Net Profit
2.33
2.30
1.30%
Operating Profit Margin (Excl OI)
42.42%
42.43%
-0.01%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 1.24% vs 13.28% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 1.30% vs 4.07% in Sep 2025

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Change(%)
Net Sales
35.17
NA
NA
Operating Profit (PBDIT) excl Other Income
15.45
NA
NA
Interest
0.53
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
9.11
NA
NA
Operating Profit Margin (Excl OI)
43.93%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Gujarat Kidney & Super Speciality Ltd stock-summary
stock-summary
Gujarat Kidney & Super Speciality Ltd
Micro Cap
Hospital
Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of `Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre. Subsequently, the Company name was changed to `Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad.
Company Coordinates stock-summary
Icon
No Company Details Available